药物与临床
WU Yuan;DENG Qian;ZHANG Yi;ZHANG Xianwei
ABSTRACTObjectiveTo observe whether combination of parecoxib sodium with tramadol improves the effect of patientcontrolled intravenous analgesia with sufentanil after thoracotomy. MethodsSixty patients(ASAⅠⅡ) were randomly divided into there groups: control group(group S, n=20); parecoxib sodium group(group P, n=20), in which parecoxib sodium 40 mg was intravenously administered 0.5 h before operation; combination of parecoxib sodium and tramadol group (group C, n=20), in which parecoxib sodium was intravenously injected 0.5 h before operation and tramadol 2 mg8226;kg1 was administrated 0.5 h before the end of operation. The visual analogue scale (VAS) for asssessing resting and motion pain, the actual/effective number of PCA, the level of restlessness and residence time in PACU at 0.5,8,12,24,48 h postoperatively were evaluated and recorded, the side effects and overall satisfaction to analgesic therapy were questioned at 48 h. ResultsThe resting and motion VAS of pain were significantly lower in group C and group P compared to those in group S at each time points postoperatively(P<0.05), the resting VAS of pain in group C and group P were separately recorded as 1.80±0.52 and 2.50±0.95 (P<0.05), and the motion VAS of pain were 2.85±0.76 and 3.30±1.38 (P<0.05); The effective number of PCA was significantly fewer in group C and group P than that in group S; The rates of restlessness were 10.0%, 50.0% and 90.0% in group C, group P and group S(P<0.05). No significant differences among three groups of the residence time at PACU and side effects were found(P>0.05). The overall satisfaction to analgesic therapy of group C and group P were similar(P>0.05), and better than group S(P<0.05). ConclusionIntravenous parecoxib sodium combining with tramadol can improve the effect of patientcontrolled intravenous analgesia with sufentanil after thoracotomy.